Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome

Fig. 4

Presence of CCR5 pools in Breast Cancer Patients and Their Clinical Significance. a Number of TACs in blood compared to average number of CCR5 pools in the cells. Patients with more TACs had a significantly higher average number of CCR5 pools. CCR5 expression: Negative = 0 pools, Low = 1–9 pools and High = 10 + pools. b Relationship of average number of CCR5 pools for CTCs and CAMLs with total number of these cells in the patient. (c and d) Kaplan–Meier analysis stratifying patients based on their average number of CCR5 pools in CAMLs. (e and f) Kaplan–Meier analysis stratifying patients based on their average number of CCR5 pools in CTCs

Back to article page